EWM
EDIT icon

Evolution Wealth Management’s Editas Medicine EDIT Stock Holding History

Evolution Wealth Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$162 Hold
50
– – ﹤0.01% 923
2026
Q1 		$124 Hold
50
– – ﹤0.01% 840
2025
Q4 		$103 Buy
+50
New +$144 ﹤0.01% 738

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Evolution Wealth Management's EDIT Position: Q2 2026 in Review

Evolution Wealth Management held its Editas Medicine (EDIT) position steady in Q2 2026 at 50 shares worth $162. The position accounts for ﹤0.01% of the portfolio, ranked #923.

Evolution Wealth Management first reported a position in EDIT in Q4 2025 and has held it in 3 quarters since. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Evolution Wealth Management held 50 shares of Editas Medicine worth $162 as of Q2 2026.
  • Evolution Wealth Management left its Editas Medicine share count unchanged in Q2 2026.
  • Editas Medicine made up ﹤0.01% of Evolution Wealth Management's portfolio in Q2 2026, its #923 holding.
  • Evolution Wealth Management first reported a position in Editas Medicine in Q4 2025 and has held it in 3 quarters since.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Evolution Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.